President Donald Trump on Saturday was administered a first dose of dexamethasone, a widely available steroid, to help fight his coronavirus infection, White House physician Sean Conley announced Sunday.
Trump was admitted to Walter Reed National Military Medical Center on Friday, just hours after revealing he and first lady Melania Trump tested positive for the virus.
Advertisement
During the course of his illness, Trump has received a single infusion of an experimental coronavirus treatment developed by the biotech company Regeneron Pharmaceuticals; at least two doses of remdesivir, an antiviral drug that the Food and Drug Administration has authorized for emergency use in hospitalized coronavirus patients; and at least one dose of dexamethasone.
Here’s what we know about dexamethasone:
Dexamethasone is a cheap, widely available steroid that provides relief for inflammation, according to the Mayo Clinic. It is used to treat several different conditions, including arthritis, allergic reactions, breathing problems and skin diseases.
Scientists in the U.K. announced in May that a clinical trial showed dexamethasone improved the chances of survival for critically ill COVID-19 patients.
The trial randomly assigned 2,104 patients to receive the drug and compared their experience with 4,321 patients who underwent normal treatment. The drug was administered either orally or intravenously.
Advertisement
Dexamethasone reduced deaths by 35% in patients who required breathing machines during their treatment and by 20% in those who only needed supplemental oxygen, according to the scientists.
The drug, however, did not appear to help less ill patients. In fact, patients who were given dexamethasone but were not receiving respiratory support died at a higher rate than patients who did not receive the steroid.
Medical experts have warned against using dexamethasone as a prophylactic measure or too early in the course of the illness. Steroids such as dexamethasone help block a body’s immune system response, which can have a negative impact on a coronavirus patient.
“In the early phase of the illness, the immune system is your friend,” Dr. Martin Landray, the study’s senior author and a professor of medicine and epidemiology at Oxford University, told The New York Times. “It’s fighting the virus, and dampening it is not a good idea.”
Advertisement
“In the later phase, the immune system is no longer your friend — it’s responsible for the lungs failing, and dampening it down with steroids helps the situation and improves the chance of survival,” he added.
Some of the most common side effects of dexamethasone are aggression, anxiety, irritability, mental depression, mood changes and trouble thinking, according to the Mayo Clinic.
Though Trump’s medical team said during a news conference Sunday that Trump is doing “very well” and that they hope to release him from the hospital “as early as tomorrow,” some medical experts have said the dexamethasone treatment suggests he may have a long road to recovery.
“It seems like Trump is stable, but remains at high risk,” Dr. Bob Wachter, chairman of the Department of Medicine at the University of California, San Francisco, tweeted Sunday following the news conference.
Citing Trump’s two reported episodes of below-normal blood oxygen levels, Wachter said the optimism from the president’s doctors “are clearly at Trump’s direction.”
Advertisement
“No way he’s ready for discharge tomorrow,” Wachter tweeted Sunday.
Our 2024 Coverage Needs You
It's Another Trump-Biden Showdown — And We Need Your Help
The Future Of Democracy Is At Stake
Our 2024 Coverage Needs You
Your Loyalty Means The World To Us
As Americans head to the polls in 2024, the very future of our country is at stake. At HuffPost, we believe that a free press is critical to creating well-informed voters. That's why our journalism is free for everyone, even though other newsrooms retreat behind expensive paywalls.
Our journalists will continue to cover the twists and turns during this historic presidential election. With your help, we'll bring you hard-hitting investigations, well-researched analysis and timely takes you can't find elsewhere. Reporting in this current political climate is a responsibility we do not take lightly, and we thank you for your support.
The 2024 election is heating up, and women's rights, health care, voting rights, and the very future of democracy are all at stake. Donald Trump will face Joe Biden in the most consequential vote of our time. And HuffPost will be there, covering every twist and turn. America's future hangs in the balance. Would you consider contributing to support our journalism and keep it free for all during this critical season?
HuffPost believes news should be accessible to everyone, regardless of their ability to pay for it. We rely on readers like you to help fund our work. Any contribution you can make — even as little as $2 — goes directly toward supporting the impactful journalism that we will continue to produce this year. Thank you for being part of our story.
It's official: Donald Trump will face Joe Biden this fall in the presidential election. As we face the most consequential presidential election of our time, HuffPost is committed to bringing you up-to-date, accurate news about the 2024 race. While other outlets have retreated behind paywalls, you can trust our news will stay free.
But we can't do it without your help. Reader funding is one of the key ways we support our newsroom. Would you consider making a donation to help fund our news during this critical time? Your contributions are vital to supporting a free press.
As Americans head to the polls in 2024, the very future of our country is at stake. At HuffPost, we believe that a free press is critical to creating well-informed voters. That's why our journalism is free for everyone, even though other newsrooms retreat behind expensive paywalls.
Our journalists will continue to cover the twists and turns during this historic presidential election. With your help, we'll bring you hard-hitting investigations, well-researched analysis and timely takes you can't find elsewhere. Reporting in this current political climate is a responsibility we do not take lightly, and we thank you for your support.
Thank you for your past contribution to HuffPost. We are sincerely grateful for readers like you who help us ensure that we can keep our journalism free for everyone.
The stakes are high this year, and our 2024 coverage could use continued support. Would you consider becoming a regular HuffPost contributor?
Dear HuffPost Reader
Thank you for your past contribution to HuffPost. We are sincerely grateful for readers like you who help us ensure that we can keep our journalism free for everyone.
The stakes are high this year, and our 2024 coverage could use continued support. If circumstances have changed since you last contributed, we hope you'll consider contributing to HuffPost once more.